Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Arthritis Rheum (2005) 52(10):300414
What it claims 'Accelerates tissue repair', 'heals tendons and gut lining', 'reverses joint wear' mostly attached to BPC-157 and TB-500 'Builds collagen from the inside', 'firmer skin in 8 weeks', 'stronger hair and nails' collagen peptides and GHK-Cu 'Master antioxidant', 'detoxifies at the cellular level' oral and liposomal glutathione 'Growth-hormone optimisation without the risks' CJC-1295/Ipamorelin and other secretagogue stacks 'Research grade', 'pharmaceutical purity', '99%+ HPLC verified' the standard reassurance on grey-market sites What the label is not telling you BPC-157 is not an approved drug anywhere, and the human evidence is close to zero
using it to reduce abdominal fat outside that indication is an off-label application that should be discussed directly with a prescribing provider, and like the GLP-1 drugs above, it requires a prescription rather than being sold over the counter
Tirzepatide accounts for fewer nerve-sensitivity reports than semaglutide, but no incidence has been established
